 The secreted koebnerisin (S100A15) acts as a chemoattractant, enhances inflammation and thus could drive breast carcinogenesis.Koebnerisin (S100A15) is overexpressed in inflammatory skin diseases, such as psoriasis and eczema.It is regulated through Th1 and Th17 but not Th2 proinflammatory cytokines.